Kenneth T. Mills
Chairman
REGENXBIO Inc. (RGNX)Board Member
REGENXBIO Inc. (RGNX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth T. Mills
Kenneth T. Mills is recorded as Chairman and Board Member at REGENXBIO Inc. (RGNX). REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Kenneth T. Mills was appointed Chairman of the Board. The proxy statement of REGENXBIO Inc. reports total compensation of $5,507,038 for Kenneth T. Mills in fiscal 2024, including a base salary of $340,998. Disclosed compensation is on record for 7 fiscal years.
“Mr. Mills will continue to serve as a director and has been named Chairman of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-13–present
-
Current
2009-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
- George Migausky Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | REGENXBIO Inc. (RGNX) | Former President and CEO | $340,998 | $5,507,038 |
| 2023 | REGENXBIO Inc. (RGNX) | Former President and CEO | $676,790 | $5,916,713 |
| 2022 | REGENXBIO Inc. (RGNX) | Former President and CEO | $650,759 | $5,753,713 |
| 2021 | REGENXBIO Inc. (RGNX) | President and CEO | $631,805 | $8,622,941 |
| 2020 | REGENXBIO Inc. (RGNX) | President and CEO | $613,403 | $7,644,087 |
| 2019 | REGENXBIO Inc. (RGNX) | President and CEO | $595,537 | $6,147,269 |
| 2018 | REGENXBIO Inc. (RGNX) | President and CEO | $546,364 | $4,938,199 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.